The Grin That Keeps On Giving: Paramount Officially Greenlights Smile 3 with Director David Bruckner

Executive Overview

The malevolent, wide-mouthed contagion that terrified global audiences is officially returning for another installment. Paramount Pictures has greenlit Smile 3, securing its place as one of the studio’s premier contemporary horror franchises. With a cumulative global box office gross soaring past the $350 million mark, the series has proven that existential dread wrapped in an unnerving, unblinking smile is a recipe for box office gold.

However, the third entry in the franchise will feature a significant creative transition behind the camera. Franchise architect Parker Finn—the writer-director who brought the eerie entity to life in the 2022 breakout hit and its 2024 sequel—is stepping aside from the director’s chair as he focuses on his upcoming cinematic reboot of Possession. Stepping in to inherit the cursed mantle is acclaimed horror filmmaker David Bruckner, best known for his work on Hulu’s Hellraiser reboot, The Night House, and The Ritual.

While Bruckner will direct, the film will honor Finn’s foundational vision. Smile 3 will be based on a cohesive multi-film narrative arc that Finn originally mapped out when he first conceived Smile as a potential trilogy. Tasked with translating that roadmap into a shooting script is accomplished screenwriter Nick Antosca (Verity, Cape Fear, Channel Zero).

As Bruckner takes the reins amidst a packed slate of high-profile horror projects—including Warner Bros.’ upcoming The Blob remake, A24’s mysterious Mice, and the Sydney Sweeney-starrer The Caretaker—the horror community is watching closely. Smile 3 represents a pivotal moment for the franchise: a test of whether a major horror property can successfully transition directors while maintaining its unique brand of psychological terror, stylistic dread, and inescapable doom.

Detailed Chronology: From Streaming Experiment to Box Office Juggernaut

To understand the magnitude of the Smile 3 greenlight, it is essential to trace the unlikely trajectory of the franchise. What began as a modest mid-budget horror concept evolved into a dominant theatrical force through a combination of savvy studio pivoting, viral marketing, and strong word-of-mouth.

2022: The Accidental Theatrical Blockbuster

When production wrapped on the original Smile, Paramount Pictures initially envisioned the film as a streaming-exclusive title destined for Paramount+. However, following remarkably strong reactions during early test screenings, studio executives made a bold bet on the film’s theatrical potential.

That gamble paid off exponentially. Released in theaters in September 2022, Smile defied industry expectations. Starring Sosie Bacon as Dr. Rose Cotter—a psychiatrist tormented by a supernatural, trauma-feeding entity that forces its victims to wear horrific, unblinking grins before gruesomely dying—the film struck a nerve with audiences.

Operating on a modest budget, Smile grossed an impressive $107 million domestically and pulled in another $217 million globally, ultimately finishing its theatrical run as the highest-grossing original horror movie of 2022. Its success was further amplified by an ingenious, albeit creepy, guerrilla marketing campaign that saw actors sitting motionless behind home plate at live Major League Baseball games while staring menacingly into the television cameras with dead-eyed grins.

2024: Expanding the Curse in Smile 2

Buoyed by the massive success of the first film, Paramount quickly locked down Parker Finn to develop a continuation. Rather than simply repeating the trauma-therapist dynamic of the original, Smile 2 (released in October 2024) drastically expanded the scope and scale of the mythology.

The sequel shifted its focus to the glittering, high-pressure world of international pop superstardom. Naomi Scott starred as Skye Riley, a global pop icon attempting a grueling comeback tour while battling past addiction, physical trauma, and the relentless psychological torture of the grinning entity.

While Smile 2 did not quite match the historic domestic heights of its predecessor, it was met with widespread critical acclaim. Critics praised Scott’s fearless, physically demanding lead performance, Finn’s escalating surrealist direction, and the film’s willingness to explore the toxic intersections of celebrity culture, mental health, and public scrutiny. The sequel proved its staying power by hauling in a respectable $139 million worldwide, solidifying Smile as a legitimate, multi-film cinematic universe rather than a one-hit wonder.

The Present: Passing the Torch to David Bruckner

With the announcement of Smile 3, the franchise enters its next evolutionary phase. Parker Finn, who has become one of modern horror’s most sought-after auteurs, is currently occupied with his high-profile reboot of Andrzej Żuławski’s legendary 1981 psychological horror classic, Possession.

Rather than rushing a third film or letting the property sit dormant, Paramount opted to bring in David Bruckner. According to reports from Variety, Bruckner will direct Smile 3 using the overarching story arc that Finn carefully constructed when he originally envisioned the property as a three-part saga. This ensures continuity in the mythology, even as a new creative voice takes charge of the execution.

Supporting Context & Metrics: The Franchise at a Glance

The Smile franchise occupies a lucrative and critically respected space in contemporary studio horror. In an era dominated by established IP, cinematic universes, and legacy sequels, Smile stands out as a rare modern success story: an original concept that built its audience organically.

Box Office Breakdown

• Smile (2022):
  • Domestic Gross: ~$107 million
  • International Gross: ~$110 million
  • Global Total: ~$217 million
  • Status: Highest-grossing original horror film of 2022.
• Smile 2 (2024):
  • Global Total: ~$139 million
  • Status: Critically praised expansion of the mythology, proving franchise durability.
• Combined Franchise Gross: $356+ million on relatively modest production budgets.

Behind the Creative Team

The transition of creative leadership brings together some of the most dynamic talents currently working within the genre ecosystem:

• David Bruckner (Director): Known for his atmospheric dread and mastery of tension. Beyond his 2022 Hellraiser reboot for Hulu, Bruckner’s filmography includes the acclaimed Netflix folk-horror film The Ritual (2017) and Searchlight Pictures’ psychological thriller The Night House (2020), which starred Rebecca Hall in a critically lauded lead performance. Bruckner is also attached to several major upcoming projects, including a reimagining of The Blob for Warner Bros., A24’s mystery-horror project Mice, and The Caretaker, which will star Sydney Sweeney.
• Nick Antosca (Screenwriter): An established heavyweight in dark television and literary adaptations, Antosca created the critically acclaimed true-crime anthology series The Act for Hulu and Syfy’s Channel Zero. His feature writing credits include the upcoming adaptations of Colleen Hoover’s bestselling thriller Verity and Martin Scorsese’s remake of Cape Fear, making him uniquely equipped to craft a tightly wound, psychologically intricate screenplay for Smile 3.
• Parker Finn (Creator / Producer): Having established the visual language, lore, and psychological framework of the franchise, Finn transitions into an overarching guiding role, ensuring that his original trilogy blueprint remains intact as new creative forces step in to execute it.

Future Outlook: What to Expect from Smile 3

As pre-production ramps up, speculation among horror fans has reached a fever pitch regarding where the franchise can go next. The ending of Smile 2 left the entity’s contagion spreading wider than ever before, transitioning from intimate, one-on-one transmissions to public arenas watched by thousands.

Exploring the Scale of the Entity

The first film operated on an intimate, suffocating scale within a clinical environment. The second film utilized the fishbowl reality of celebrity culture, where every move is recorded, judged, and broadcast to millions. With Smile 3, the natural progression of the mythology suggests a potential societal breakdown. If the entity’s transmission line has been multiplied exponentially on a public stage, the third film could explore a full-blown contagion outbreak, testing how humanity reacts when an invisible, inescapable curse infects the general population en masse.

The Bruckner Touch

David Bruckner’s directorial style heavily favors psychological deterioration, grief, and atmospheric dread—themes that align perfectly with the DNA of the Smile franchise. While Parker Finn’s direction relied heavily on sharp jump scares, surrealist dream logic, and distorted spatial awareness, Bruckner brings a heavier, more melancholic sense of dread to his projects (as seen in The Night House). The fusion of Finn’s nightmarish creature mechanics with Bruckner’s knack for existential despair could yield the darkest and most emotionally taxing installment of the trilogy yet.

Release Expectations and Production Timeline

While Paramount Pictures has not yet announced an official release date for Smile 3, the assembly of a top-tier creative team—pairing Bruckner with screenwriter Nick Antosca—signals that the studio is prioritizing quality and momentum. Given Bruckner’s busy schedule, principal photography is anticipated to begin once his current slate of commitments allows, pointing toward a potential late 2026 or 2027 theatrical release.

One thing is certain: the horror community has not seen the last of the grin. As Paramount continues to cultivate high-performing theatrical horror, Smile 3 stands as one of the most anticipated genre releases on the horizon, promising to push its characters—and its audience—right back to the edge of sanity.